Solugen, a Texas-based chemical manufacturer pioneering scalable domestic production of critical materials for defense and industrial applications, announced a partnership with American Rheinmetall Munitions (ARM), a leading U.S. provider of innovative munitions technologies headquartered in Vienna, VA. Together, the companies will expand the availability of affordable, U.S.-made energetics.
The collaboration brings together Solugen’s ability to lower the cost and improve the availability of critical energetics inputs with ARM’s proven capacity to integrate those materials into advanced munitions and deliver them to the warfighter. The companies will reinforce the resilience of the U.S. defense industrial base and ensure that affordability and availability remain central to America’s overmatch advantage.
This partnership highlights ARM’s role as an early mover in adopting new solutions while underscoring Solugen‘s broader commitment to work across the defense ecosystem—helping primes, integrators, and the government alike secure affordable, CONUS-based supply chains for energetics.
Also Read: HavocAI Raises $85M to Scale Autonomy Capabilities
“Our collaboration with Solugen enhances the scalability and speed at which we can deliver advanced energetics, while driving down cost. It’s a strategic step that strengthens the U.S. defense industrial base and ensures critical technologies reach the Warfighter faster,” Gary Goodwin, CEO, American Rheinmetall Munitions.
“Solugen is committed to helping the defense community secure resilient, U.S.-based supply chains while bending the cost curve for next-gen energetics,” said Sean Hunt, PhD, co-founder and Chief Technology Officer of Solugen. “By collaborating with ARM—and with other leaders across the sector-we’re building pathways that make advanced energetics more affordable and more accessible for America’s defense.”
In parallel, Solugen continues its important work under the Department of War’s Distributed Bioindustrial Manufacturing Program (DBIMP), where it was awarded a contract to advance bioindustrial manufacturing capabilities and scale up critical defense-relevant molecules. This program directly complements Solugen’s partnership with ARM by ensuring resilient, domestic production of precursors that feed into advanced energetics.
SOURCE: PRNewswire